Dermatology
Medicines

Dermatology Medicine Supply for Hospitals & International Buyers

Skin conditions represent one of the most prevalent disease categories worldwide, with dermatological disorders affecting an estimated 1.9 billion people at any given time. In the GCC region and across Africa, the burden is particularly significant: eczema and atopic dermatitis are driven by arid, high-temperature climates; psoriasis affects patients of all ethnic backgrounds; acne is among the most common conditions seen in GCC outpatient dermatology clinics; fungal skin infections including tinea and candidiasis are endemic in tropical and subtropical African climates; and disorders of pigmentation such as melasma and post-inflammatory hyperpigmentation carry a high psychosocial burden in darker skin phototypes. Euro Biom supplies dermatological medicines from the UK pharmaceutical market to hospitals, dermatology departments and international healthcare buyers across these regions.

Our topical corticosteroid sourcing covers the full potency spectrum required for safe and effective dermatological prescribing. Mild preparations include hydrocortisone 0.5% and 1% in cream and ointment. Moderate-potency options include clobetasone butyrate 0.05% and betamethasone valerate 0.025%. The potent range covers betamethasone valerate 0.1%, betamethasone dipropionate, mometasone furoate and fluticasone propionate in cream, ointment and lotion formulations. Very potent preparations, including clobetasol propionate 0.05%, are available for short-term use in refractory conditions. Combination products pairing corticosteroids with an antibacterial or antifungal agent are also within our sourcing range.

Topical antibiotics and antifungals are essential components of dermatology formularies in any market. Euro Biom sources fusidic acid cream and ointment, mupirocin 2% for decolonisation and superficial skin infections, and a full range of topical antifungal agents including clotrimazole, miconazole, econazole, terbinafine and nystatin. These are available in cream, gel, powder and spray formulations. Combined antifungal-corticosteroid preparations are also available for inflammatory dermatophyte and candidal infections.

Acne is a leading reason for dermatology referral in GCC countries and across Africa, and effective treatment requires access to a full therapeutic ladder. Euro Biom supplies topical retinoids (tretinoin 0.025%, 0.05% and 0.1%; adapalene 0.1% and 0.3%), benzoyl peroxide in multiple strengths, topical clindamycin and combination clindamycin-benzoyl peroxide preparations. Oral isotretinoin, the definitive treatment for severe nodulocystic and scarring acne, is subject to stringent restrictions in many countries outside the UK; Euro Biom can supply UK-licensed oral isotretinoin capsules to buyers with appropriate prescribing and dispensing authorisation in their jurisdiction.

Systemic Treatments for Psoriasis and Atopic Dermatitis

Moderate-to-severe psoriasis and atopic dermatitis require systemic therapies that are frequently unavailable or inconsistently supplied in GCC and African markets. Euro Biom sources the full range of conventional systemics: methotrexate tablets and injectable solution, ciclosporin capsules and oral solution, and acitretin capsules. For psoriasis, the biologic portfolio includes adalimumab (originator and biosimilars), secukinumab, ixekizumab, guselkumab and risankizumab. For atopic dermatitis, dupilumab has transformed outcomes and is increasingly prescribed in specialist centres across the Gulf; Euro Biom can source dupilumab pre-filled syringes where local supply is unavailable or delayed. All biologics are handled under full GDP-compliant cold chain conditions.

Emollients and barrier preparations are the cornerstone of eczema management and their importance is heightened in the GCC, where low humidity and air-conditioning create chronically dry skin conditions that compromise the epidermal barrier. Euro Biom supplies a range of emollient creams, ointments and bath additives, including white soft paraffin, emulsifying ointment, aqueous cream, urea-containing preparations and specialist lipid-rich formulations. These products are often requested alongside prescription medicines as part of a holistic eczema management package for hospitals and dermatology departments in the Gulf.

GCC and African dermatology units source from the UK for a number of specific clinical and regulatory reasons. Biologic therapies approved and marketed in the UK, including newer IL-17, IL-23 and IL-4/IL-13 inhibitors, may not yet have local market authorisation or reliable local distribution. Oral isotretinoin is subject to restrictive pregnancy prevention programmes that limit commercial availability in some Gulf markets. Brand-specific prescribing is common in GCC hospital formularies, and some branded UK products are preferred over locally available generics due to formulation differences. In shortage situations, UK wholesale supply through a licensed WDA holder such as Euro Biom provides a compliant and auditable procurement route.

Euro Biom holds a UK Wholesale Dealer Authorisation (WDA) and operates under Good Distribution Practice (GDP) guidelines, providing a fully compliant supply chain for dermatological medicines from basic topicals to high-value biologics. We supply individual product lines, multi-product orders and urgent named-patient requirements. Our team responds to procurement enquiries within one business day with confirmed availability and pricing. Contact us with your dermatology product list and we will provide a tailored supply proposal.